USANA Health Sciences, Inc. (NYSE:USNA) Director Frederic J. Winssinger sold 282 shares of the stock in a transaction dated Thursday, February 7th. The shares were sold at an average price of $105.91, for a total transaction of $29,866.62. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Shares of USNA opened at $108.51 on Friday. USANA Health Sciences, Inc. has a 12 month low of $73.15 and a 12 month high of $137.95. The company has a market cap of $2.60 billion, a PE ratio of 21.23 and a beta of 0.53.
USANA Health Sciences (NYSE:USNA) last announced its earnings results on Tuesday, February 5th. The company reported $1.32 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.33 by ($0.01). USANA Health Sciences had a return on equity of 29.94% and a net margin of 10.61%. The business had revenue of $299.02 million for the quarter, compared to the consensus estimate of $305.79 million. During the same period in the prior year, the business posted $1.11 earnings per share. The firm’s revenue for the quarter was up 9.5% compared to the same quarter last year. On average, research analysts predict that USANA Health Sciences, Inc. will post 5.4 EPS for the current fiscal year.
Several institutional investors and hedge funds have recently made changes to their positions in the company. BlackRock Inc. increased its holdings in shares of USANA Health Sciences by 1.2% during the fourth quarter. BlackRock Inc. now owns 1,089,647 shares of the company’s stock worth $128,283,000 after purchasing an additional 13,320 shares during the period. 361 Capital LLC increased its holdings in shares of USANA Health Sciences by 71.0% during the fourth quarter. 361 Capital LLC now owns 24,780 shares of the company’s stock worth $2,917,000 after purchasing an additional 10,291 shares during the period. LPL Financial LLC increased its holdings in shares of USANA Health Sciences by 36.7% during the fourth quarter. LPL Financial LLC now owns 2,822 shares of the company’s stock worth $332,000 after purchasing an additional 757 shares during the period. First Trust Advisors LP increased its holdings in shares of USANA Health Sciences by 622.5% during the fourth quarter. First Trust Advisors LP now owns 37,309 shares of the company’s stock worth $4,392,000 after purchasing an additional 32,145 shares during the period. Finally, MERIAN GLOBAL INVESTORS UK Ltd increased its holdings in shares of USANA Health Sciences by 27.9% during the fourth quarter. MERIAN GLOBAL INVESTORS UK Ltd now owns 235,867 shares of the company’s stock worth $27,768,000 after purchasing an additional 51,401 shares during the period. 54.39% of the stock is currently owned by institutional investors.
Several research firms have weighed in on USNA. ValuEngine cut shares of USANA Health Sciences from a “buy” rating to a “hold” rating in a report on Thursday, November 8th. Sidoti raised shares of USANA Health Sciences from a “neutral” rating to a “buy” rating in a report on Thursday, October 25th. Finally, Pivotal Research raised shares of USANA Health Sciences from a “hold” rating to a “buy” rating and set a $135.00 price target on the stock in a report on Wednesday, October 24th.
TRADEMARK VIOLATION NOTICE: “Frederic J. Winssinger Sells 282 Shares of USANA Health Sciences, Inc. (USNA) Stock” was originally reported by Dakota Financial News and is the sole property of of Dakota Financial News. If you are reading this article on another site, it was illegally copied and republished in violation of US and international copyright and trademark law. The correct version of this article can be viewed at https://dakotafinancialnews.com/2019/02/10/frederic-j-winssinger-sells-282-shares-of-usana-health-sciences-inc-usna-stock.html.
About USANA Health Sciences
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.
Featured Article: How to Track your Portfolio in Google Finance
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.